""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subObsID"	"uniqObsID"	"response_agent_original"	"signature_file"	"complete_signature_file"
"subject"	""	""	""	"cell_subset"	"gene"	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	""	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"	"file"
"role"	""	""	""	"tissue"	"gene_biomarker"	"background"	"measured"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"background"	"observed"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	"comments and additional details"	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (gene symbol)"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year (influenza only)"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"figure or table or text section containing signature"	"comment"	"Qi et al. (2016) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598' target='_blank'>27030598</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"original gene symbol"	"signature response agents file"	"complete signature response agents file"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-4"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV5-4"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-5"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV5-5"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-8"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV5-8"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV6-1"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV6-1"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV7-3"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV7-3"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV7-4"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV7-4"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV12-4"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"1"	"312"	"TRBV12-4"	"hipciof_gene_27030598_312.txt"	"hipciof_gene_complete_27030598_312.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-8"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"2"	"313"	"TRBV5-8"	"hipciof_gene_27030598_313.txt"	"hipciof_gene_complete_27030598_313.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV7-3"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"2"	"313"	"TRBV7-3"	"hipciof_gene_27030598_313.txt"	"hipciof_gene_complete_27030598_313.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV7-4"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"2"	"313"	"TRBV7-4"	"hipciof_gene_27030598_313.txt"	"hipciof_gene_complete_27030598_313.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV12-4"	"gene expression"	"up"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"2"	"313"	"TRBV12-4"	"hipciof_gene_27030598_313.txt"	"hipciof_gene_complete_27030598_313.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV10-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV10-3"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV14"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV14"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV15"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV15"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV19"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV19"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV20-1"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV20-1"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV4-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV4-3"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBV5-3"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBJ2-1"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"314"	"TRBJ2-1"	"hipciof_gene_27030598_314.txt"	"hipciof_gene_complete_27030598_314.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV10-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV10-3"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV14"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV14"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV15"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV15"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV19"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV19"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV20-1"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV20-1"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV4-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV4-3"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBV5-3"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBV5-3"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBJ1-4"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBJ1-4"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBJ1-5"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBJ1-5"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
""	"20161219-hipciof_gene_27030598"	"2016.12.19"	"hipciof_gene_40"	"CD4-positive, alpha-beta T cell"	"TRBJ2-1"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"CD4-positive T cell vs naive CD4-positive T cell"	"time of vaccination (first dose)"	"seniors (52-75)"	"27030598"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"4"	"315"	"TRBJ2-1"	"hipciof_gene_27030598_315.txt"	"hipciof_gene_complete_27030598_315.txt"
